Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32470238!ä!32470238 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32470238.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Am+J+Dent 2020 ; 33 (3): 135-137 Nephropedia Template TP {{tp|p=32470238|t=2020. Taste and smell as chemosensory dysfunctions in COVID-19 infection |pdf=|usr=}}{{32470238}} gab.com Text Taste and smell as chemosensory dysfunctions in COVID-19 infection JO: Am J Dent http://www.kidney.de/pget.php?&tw=1&pmid=32470238 #FOAvip PURPOSE: To review the literature on the presence of two clinical manifestations in patients presenting COVID-19 (SARS-CoV-2) infection: loss of taste (ageusia) and loss of smell (anosmia). METHODS: PubMed and EMBASE were searched and studies were selected starting from November, 2019 until April 2020; also, the references of the selected articles were evaluated for methodological quality. RESULTS: Of the 19 studies analyzed, five were included to evaluate the presence of ageusia and/or anosmia as symptoms in patients who were tested and resulted positive for the SARS-CoV-2 virus. In a total of 10,818 patients, 8,823 presented ageusia (81.6%; range 5.6%-88%) and 8,088 presented anosmia (74.8%; range 5.1-85.6%). Only one study recorded both symptoms with a percentage of 18.6%. CLINICAL SIGNIFICANCE: This systematic review demonstrated significant presence of ageusia and anosmia in the patients with COVID-19 infection. These symptoms may be considered as the first manifestation of the infection. Twit Text FOAVip Taste and smell as chemosensory dysfunctions in COVID-19 infection ????Am J Dent http://www.kidney.de/pget.php?&tw=1&pmid=32470238 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32470238 #FOAvip English Wikipedia <ref>{{Cite pmid|32470238}}</ref> Taste and smell as chemosensory dysfunctions in COVID-19 infection #MMPMID32470238 Passarelli PC; Lopez MA; Mastandrea Bonaviri GN; Garcia-Godoy F; D'Addona A Am J Dent 2020[Jun]; 33 (3): 135-137 PMID32470238show ga PURPOSE: To review the literature on the presence of two clinical manifestations in patients presenting COVID-19 (SARS-CoV-2) infection: loss of taste (ageusia) and loss of smell (anosmia). METHODS: PubMed and EMBASE were searched and studies were selected starting from November, 2019 until April 2020; also, the references of the selected articles were evaluated for methodological quality. RESULTS: Of the 19 studies analyzed, five were included to evaluate the presence of ageusia and/or anosmia as symptoms in patients who were tested and resulted positive for the SARS-CoV-2 virus. In a total of 10,818 patients, 8,823 presented ageusia (81.6%; range 5.6%-88%) and 8,088 presented anosmia (74.8%; range 5.1-85.6%). Only one study recorded both symptoms with a percentage of 18.6%. CLINICAL SIGNIFICANCE: This systematic review demonstrated significant presence of ageusia and anosmia in the patients with COVID-19 infection. These symptoms may be considered as the first manifestation of the infection. |*Coronavirus Infections[MESH] |*Olfaction Disorders/virology[MESH] |*Pneumonia, Viral[MESH] |*Smell[MESH] |*Taste Disorders/virology[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Humans[MESH] |Pandemics[MESH] |SARS-CoV-2[MESH]Taste and smell as chemosensory dysfunctions in COVID-19 infection (epmc).pdf DeepDyve Pubget Overpricing